Chronic itch is a symptom of many skin conditions and systemic disease, and it has been hypothesized that the chronic itch may result from sensitization of itch-signaling pathways. We induced experimental chronic dry skin on the rostral back of mice, and observed a significant increase in spontaneous hindlimb scratches directed to the dry skin. Spontaneous scratching was significantly attenuated by a PAR-2 antibody and 5-HT2A receptor antagonist, indicating activation of these receptors by endogenous mediators released under dry skin conditions. We also observed a significant increase in the number of scratch bouts evoked by acute intradermal injections of a protease-activated receptor (PAR)-2 agonist and serotonin (5-HT), but not histamine. We additionally investigated if pruritogen-evoked activity of dorsal root ganglion (DRG) neurons is enhanced in this model. DRG cells from dry skin mice exhibited significantly larger responses to the PAR-2 agonist and 5-HT, but not histamine. Spontaneous scratching may reflect ongoing itch, and enhanced pruritogen-evoked scratching may represent hyperknesis (enhanced itch), both potentially due to sensitization of itch-signaling neurons. The correspondence between enhanced behavioral scratching and DRG cell responses suggest that peripheral pruriceptors that respond to proteases and 5-HT, but not histamine, may be sensitized in dry skin itch. Ó
Introduction
Chronic itch associated with dermatitis, liver or kidney disease, HIV and many other conditions represents a large and poorly treated medical condition worldwide [5] . Our understanding of the neural basis for normal itch transmission is at a beginning stage, and virtually nothing is known about pathophysiological changes associated with chronic itch. Sensitization of itch-signaling pathways has been suggested as a mechanism underlying chronic itch of atopic dermatitis patients, since histamine elicits greater itch, and noxious stimuli elicit itch instead of pain in lesional skin [15, 16] . Sensitization may be triggered by spontaneous firing of pruriceptors from lesional skin [25] , and the switch from pain to itch may reflect a pathological reduction in the normal inhibitory effect of pain on itch transmission.
To date, there have been few if any experimental studies of itch sensitization associated with dermatitis. We addressed this issue by investigating if scratching, a behavioral manifestation of itch, is enhanced in an animal model of chronic dry skin itch [20, 22] . In this model, chronic dry skin is induced by twice-daily skin treatments with acetone:ether (50:50) followed by water (AEW) over a 5-to 7-day period. This results in a significant increase in the number of spontaneous hindlimb scratch bouts directed to the dry skin treatment area on the rostral back, accompanied by an increased epidermal thickness, decreased stratum corneum hydration and an increased transepidermal water loss of the treated skin area [20] . We reasoned that chronic dry skin itch would sensitize itch-signaling pathways, such that mice would exhibit increased spontaneous scratching as a manifestation of chronic ongoing itch and increased scratching to acute challenge with intradermally injected pruritogens. One potential mechanism contributing to enhanced scratching is peripheral sensitization of pruritogen-responsive primary afferent fibers. To test this possibility, we investigated dorsal root ganglion (DRG) cells from cervical segments innervating skin on the rostral back. We tested if DRG cells from mice receiving AEW treatment on the rostral back exhibited a higher incidence of responsiveness to pruritogens, and if their pruritogen-evoked responses were larger, compared to DRG cells taken from control mice. We presently tested histamine, serotonin (5-HT) and an agonist of the protease-activated receptor type 2 (PAR-2), all of which elicit dose-dependent scratching behavior in mice [2, 7, 26, 31] . Histamine is a prototypical itch mediator in humans, serotonin elicits mild itch [9] , and PAR-2 has recently been implicated in chronic itch of atopic dermatitis [27] .
